Clinical Trial Update: Observational Study to Evaluate the Safety of Levemir® in Diabetes

View source ↗

Summary

An observational safety study evaluating Levemir (insulin detemir) in people with diabetes has completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED | Results posted: 2011-08-16